|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.55 USD | +4.16% |
|
-13.37% | +40.85% |
| 05-11 | Celanese's H2 Guide Appears Conservative, RBC Says | MT |
| 05-11 | Celanese Raises Prices Across Acetyl Chain Products, Effective Immediately | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.16 | 4.95 | 2.72 | 2.75 | 2.33 | |||||
Return on Total Capital | 15.31 | 6.32 | 3.35 | 3.38 | 2.89 | |||||
Return On Equity % | 45.49 | 35.9 | 28.89 | -22.89 | -22.52 | |||||
Return on Common Equity | 49.57 | 38.71 | 30.94 | -24.69 | -24.93 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.42 | 24.6 | 23.79 | 23.61 | 20.57 | |||||
SG&A Margin | 6.17 | 7.13 | 10.46 | 10.21 | 8.84 | |||||
EBITDA Margin % | 28.34 | 20.42 | 16.74 | 17.49 | 16.38 | |||||
EBITA Margin % | 24.2 | 16.22 | 11.61 | 11.72 | 9.97 | |||||
EBIT Margin % | 23.94 | 15.67 | 10.5 | 10.58 | 8.7 | |||||
Income From Continuing Operations Margin % | 22.47 | 19.75 | 18.03 | -14.65 | -11.84 | |||||
Net Income Margin % | 22.14 | 19.58 | 17.92 | -14.81 | -12.21 | |||||
Net Avail. For Common Margin % | 22.4 | 19.66 | 18 | -14.73 | -11.99 | |||||
Normalized Net Income Margin | 16.41 | 9.87 | 4.27 | 4.99 | 2.77 | |||||
Levered Free Cash Flow Margin | 6.53 | -1.56 | 9.84 | 4.96 | 3.86 | |||||
Unlevered Free Cash Flow Margin | 7.2 | 1.06 | 13.95 | 9.07 | 8.45 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.51 | 0.41 | 0.42 | 0.43 | |||||
Fixed Assets Turnover | 1.99 | 1.86 | 1.82 | 1.76 | 1.72 | |||||
Receivables Turnover (Average Receivables) | 8.74 | 7.62 | 8.34 | 8.7 | 9.34 | |||||
Inventory Turnover (Average Inventory) | 4.68 | 3.37 | 3.23 | 3.38 | 3.37 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.52 | 1.63 | 1.53 | 1.34 | 1.55 | |||||
Quick Ratio | 0.88 | 0.88 | 0.88 | 0.67 | 0.74 | |||||
Operating Cash Flow to Current Liabilities | 0.7 | 0.45 | 0.47 | 0.25 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 41.75 | 47.92 | 43.74 | 42.08 | 39.07 | |||||
Days Outstanding Inventory (Average Inventory) | 77.99 | 108.4 | 113.06 | 108.15 | 108.43 | |||||
Average Days Payable Outstanding | 55.8 | 56.98 | 70.07 | 64.4 | 60.87 | |||||
Cash Conversion Cycle (Average Days) | 63.94 | 99.34 | 86.73 | 85.83 | 86.63 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 92.66 | 247.76 | 186.68 | 230.91 | 289.22 | |||||
Total Debt / Total Capital | 48.1 | 71.24 | 65.12 | 69.78 | 74.31 | |||||
LT Debt/Equity | 74.41 | 225.01 | 167.19 | 202.75 | 260.71 | |||||
Long-Term Debt / Total Capital | 38.62 | 64.7 | 58.32 | 61.27 | 66.98 | |||||
Total Liabilities / Total Assets | 62.11 | 76.76 | 71.61 | 75.46 | 79.39 | |||||
EBIT / Interest Expense | 22.46 | 3.74 | 1.6 | 1.61 | 1.18 | |||||
EBITDA / Interest Expense | 27.35 | 5.12 | 2.72 | 2.86 | 2.41 | |||||
(EBITDA - Capex) / Interest Expense | 22.22 | 3.78 | 1.94 | 2.21 | 1.92 | |||||
Total Debt / EBITDA | 1.69 | 7.3 | 7.19 | 6.7 | 7.67 | |||||
Net Debt / EBITDA | 1.47 | 6.57 | 6.27 | 6.21 | 6.92 | |||||
Total Debt / (EBITDA - Capex) | 2.08 | 9.89 | 10.11 | 8.65 | 9.62 | |||||
Net Debt / (EBITDA - Capex) | 1.81 | 8.9 | 8.82 | 8.01 | 8.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 50.96 | 13.31 | 13.1 | -6.03 | -7.05 | |||||
Gross Profit, 1 Yr. Growth % | 107.42 | -11.26 | 9.37 | -6.76 | -18.45 | |||||
EBITDA, 1 Yr. Growth % | 122.54 | -18.35 | -7.76 | -2.55 | -11.94 | |||||
EBITA, 1 Yr. Growth % | 174.37 | -24.06 | -19.06 | -5.12 | -19.46 | |||||
EBIT, 1 Yr. Growth % | 178.47 | -25.83 | -24.21 | -5.31 | -22.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -4.29 | -0.42 | 3.3 | -176.33 | -25.95 | |||||
Net Income, 1 Yr. Growth % | -4.79 | 0.21 | 3.48 | -177.65 | -24.45 | |||||
Normalized Net Income, 1 Yr. Growth % | 154.76 | -31.82 | -51.15 | 9.86 | -46.99 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 1.25 | 2.05 | 3.39 | -177 | -25.61 | |||||
Accounts Receivable, 1 Yr. Growth % | 46.59 | 18.78 | -9.86 | -9.82 | -17.75 | |||||
Inventory, 1 Yr. Growth % | 55.83 | 84.25 | -16.06 | -3.1 | -2.8 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.19 | 35.4 | 0.15 | -5.74 | -3.99 | |||||
Total Assets, 1 Yr. Growth % | 9.77 | 119.39 | 1.24 | -14.06 | -5 | |||||
Tangible Book Value, 1 Yr. Growth % | 0.05 | -374.73 | -31.18 | -0.21 | -15.21 | |||||
Common Equity, 1 Yr. Growth % | 18.8 | 34.57 | 25.79 | -27.02 | -21.06 | |||||
Cash From Operations, 1 Yr. Growth % | 30.83 | 3.53 | 4.4 | -49.13 | 18.63 | |||||
Capital Expenditures, 1 Yr. Growth % | 28.3 | 16.27 | 4.6 | -23.42 | -21.15 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 5.49 | -127.51 | -865.24 | -53.26 | -33.11 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 2.97 | -83.04 | 1.26K | -39.49 | -17.14 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.68 | 0.74 | 2.19 | 0 | -95.71 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 16.44 | 30.79 | 13.2 | 3.09 | -6.54 | |||||
Gross Profit, 2 Yr. CAGR % | 29.23 | 35.67 | -1.48 | 0.98 | -13.06 | |||||
EBITDA, 2 Yr. CAGR % | 32.93 | 34.61 | -13.05 | -5.04 | -8.48 | |||||
EBITA, 2 Yr. CAGR % | 41.15 | 44.06 | -21.65 | -12.61 | -8.66 | |||||
EBIT, 2 Yr. CAGR % | 42.05 | 43.71 | -25.02 | -15.28 | -14.71 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 48.99 | -2.37 | 1.42 | -11.2 | -23.99 | |||||
Net Income, 2 Yr. CAGR % | 48.94 | -2.32 | 1.84 | -10.36 | -22.57 | |||||
Normalized Net Income, 2 Yr. CAGR % | 37.33 | 31.79 | -42.29 | -26.74 | -24.36 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 57.35 | 1.65 | 2.72 | -10.78 | -23.48 | |||||
Accounts Receivable, 2 Yr. CAGR % | 16.87 | 31.95 | 3.47 | -9.84 | -13.87 | |||||
Inventory, 2 Yr. CAGR % | 21.17 | 69.45 | 24.36 | -9.81 | -2.95 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.35 | 19.91 | 16.45 | -2.84 | -4.87 | |||||
Total Assets, 2 Yr. CAGR % | 12.42 | 55.19 | 49.03 | -6.73 | -9.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | 34.97 | 65.79 | 37.51 | -17.13 | -7.47 | |||||
Common Equity, 2 Yr. CAGR % | 29.26 | 26.44 | 30.11 | -4.19 | -24.44 | |||||
Cash From Operations, 2 Yr. CAGR % | 9.93 | 16.38 | 3.96 | -27.13 | -22.32 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.35 | 22.14 | 10.28 | -10.5 | -22.29 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -13.67 | -46.62 | 40.18 | 90.34 | -41.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -13.44 | -58.56 | 58.89 | 187.83 | -27.17 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.46 | 5.11 | 1.46 | 1.09 | -79.3 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.06 | 15.38 | 24.6 | 6.39 | -0.45 | |||||
Gross Profit, 3 Yr. CAGR % | 10.79 | 14.01 | 26.27 | -3.28 | -6.22 | |||||
EBITDA, 3 Yr. CAGR % | 14.46 | 12.99 | 18.87 | -9.45 | -7.8 | |||||
EBITA, 3 Yr. CAGR % | 16.88 | 14.8 | 18.88 | -16.49 | -15.5 | |||||
EBIT, 3 Yr. CAGR % | 17.19 | 14.38 | 16.11 | -18.96 | -18.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.34 | 30.27 | -0.52 | -7.74 | -16.05 | |||||
Net Income, 3 Yr. CAGR % | 16.12 | 30.51 | -0.42 | -6.96 | -14.96 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.34 | 8.74 | -5.33 | -28.47 | -34.85 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.99 | 36.2 | 2.23 | -6.69 | -15.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.51 | 17.5 | 16.21 | -1.16 | -12.56 | |||||
Inventory, 3 Yr. CAGR % | 13.37 | 39.34 | 34.07 | 14.44 | -7.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6 | 15.26 | 12.92 | 8.52 | -3.23 | |||||
Total Assets, 3 Yr. CAGR % | 8.74 | 40.48 | 34.59 | 24.05 | -6.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.09 | 71.05 | 23.68 | 23.57 | -16.16 | |||||
Common Equity, 3 Yr. CAGR % | 11.97 | 31.01 | 26.22 | 7.3 | -10.44 | |||||
Cash From Operations, 3 Yr. CAGR % | 4.09 | 7.75 | 12.24 | -18.08 | -14.27 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.49 | 13.64 | 15.99 | -2.34 | -14.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -1.45 | -41.39 | 26.74 | -2.38 | 37.88 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -2.09 | -50 | 36.75 | 15.52 | 92.84 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.35 | 4.52 | 4.13 | 0.97 | -64.75 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.64 | 9.52 | 8.86 | 10.3 | 11.03 | |||||
Gross Profit, 5 Yr. CAGR % | 13.8 | 9.51 | 5.71 | 8.61 | 8.71 | |||||
EBITDA, 5 Yr. CAGR % | 15.24 | 9.18 | 2.57 | 5.6 | 7.47 | |||||
EBITA, 5 Yr. CAGR % | 17.82 | 9.69 | -0.37 | 3.05 | 4.72 | |||||
EBIT, 5 Yr. CAGR % | 17.78 | 9.41 | -1.98 | 1.44 | 2.49 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.13 | 17.25 | 10.13 | 11.75 | -10.83 | |||||
Net Income, 5 Yr. CAGR % | 16 | 17.57 | 10.18 | 12.3 | -10.11 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.73 | 6.22 | -13.02 | -7.15 | -13.64 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.48 | 22.98 | 15 | 15 | -9.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.71 | 6.94 | 4.1 | 5.69 | 3.09 | |||||
Inventory, 5 Yr. CAGR % | 16.18 | 25.55 | 17.64 | 17.08 | 17.82 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.37 | 9.77 | 10.06 | 7.65 | 5.44 | |||||
Total Assets, 5 Yr. CAGR % | 7.46 | 22.46 | 23.35 | 19.26 | 14.74 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.03 | 28.79 | 19.01 | 28.01 | 10.13 | |||||
Common Equity, 5 Yr. CAGR % | 10.11 | 14.32 | 18.9 | 15.6 | 2.8 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.49 | 17.77 | 4.04 | -7.85 | -3.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.68 | 15.25 | 11.01 | 3.29 | -1.18 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.67 | -21.68 | 13.06 | -7.4 | -6.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.78 | -29.38 | 18.44 | 2.59 | 6.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.53 | 9.51 | 6.13 | 3.13 | -45.43 |
- Stock Market
- Equities
- CE Stock
- Financials Celanese Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















